Our Initiatives

As the Lung Ambition Alliance, we stand together to better understand the biology of lung cancer, support health system changes that reflect the latest science, and ultimately empower and enable patients to live longer and better lives.

We have established a range of partnerships across the globe. Learn about our global flagship and national projects.

The Lung Cancer Policy Network

Aiming to improve lung cancer survival worldwide by making lung cancer a policy priority, the Lung Cancer Policy Network brings together over 60 multidisciplinary experts from around the world, including clinicians, researchers, patient organisations and industry partners. Sharing research, reports and recommendations, the Network highlights opportunities to diagnose lung cancer earlier and optimise the way people access lung cancer care.

Find out more

Lung Ambition Alliance partnership with the World Economic Forum

Driving multi-sector collaboration to transform outcomes in lung cancer and improve the sustainability of health systems, with a broader objective of delivering the promise of the United Nations’ Sustainable Development Goal 3.4 

Find out more

Initiatives in Lung Cancer Care (ILC2)

Funding projects, through an open call to patient organizations worldwide, that can potentially transform patient care and improve survival at the local level

Find out more

Cost of Inaction

Advocating for national governments to implement targeted lung cancer screening at scale, as a cost-effective investment that reduces the public health and economic burden of disease

Find out moreblue arrow

Partnership for Health System Sustainability and Resilience

Supporting changes to health systems that improve their resilience to crises, such as the COVID-19 pandemic, and their sustainability in the face of long-term stresses

Find out more

Ambition, Improvement, Measurement (AIM)

Improving quality of care through projects focused on securing patient access to timely diagnostic testing, increasing patient access to multidisciplinary teams and improving coordination of care

Find out moreblue arrow

Pathological Response Initiative

Prioritizing the validation of surrogate endpoints and the identification of predictive biomarkers to accelerate the development of targeted treatments and drive a shift to earlier intervention where there is greater chance for cure

Find out moreblue arrow

Beyond the Diagnosis: Confronting Lung Cancer Stigma

Lung cancer stigma: a hidden burden that may delay care and harm well-being. Hear survivors’ stories and learn how we can change the conversation.

Find out moreblue arrow

Local Solutions, Global Impact

Our projects across more than 50 countries bring to life our goals of increasing screening and diagnosis, advancing innovative medicine and improving quality care.

 

Loading......

Date of Preparation: June 2022 | Document ID: Z4-45904